Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vijayakumar Velu

Showing results (101-110 of 106) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 106 results.
Plos Pathogens|June 28, 2021
Tissue-specific transcriptional profiling of plasmacytoid dendritic cells reveals a hyperactivated state in chronic SIV infectionMichelle Y-H Lee, Amit A Upadhyay, Hasse Walum, et al.
Journal of Medical Virology|February 8, 2024
Genomic surveillance of omicron B.1.1.529 SARS-CoV-2 and its variants between December 2021 and March 2023 in Tamil Nadu, India-A state-wide prospective longitudinal studySivaprakasam T Selvavinayagam, Suvaiyarasan Suvaithenamudhan, Yean K Yong, et al.
Vaccine|June 23, 2011
Prime-boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: efficacy against repeated mucosal R5 clade C SHIV challengesSamir K Lakhashe, Vijayakumar Velu, Gaia Sciaranghella, et al.
PLOS Global Public Health|November 21, 2024
Attrition in serum anti-DENV antibodies correlates with high anti-SARS-CoV-2 IgG levels and low DENV positivity in mosquito vectors-Findings from a state-wide cluster-randomized community-based study in Tamil Nadu, IndiaSivaprakasam T Selvavinayagam, Sathish Sankar, Yean K Yong, et al.
Medrxiv : the Preprint Server for Health Sciences|June 17, 2024
Serosurveillance of dengue infection and correlation with mosquito pools for dengue virus positivity during the COVID-19 pandemic in Tamil Nadu, India - A state-wide cross-sectional cluster randomized community-based studySivaprakasam T Selvavinayagam, Sathish Sankar, Yean K Yong, et al.
Nature Communications|August 8, 2023
Intradermal but not intramuscular modified vaccinia Ankara immunizations protect against intravaginal tier2 simian-human immunodeficiency virus challenges in female macaquesVenkata S Bollimpelli, Pradeep B J Reddy, Sailaja Gangadhara, et al.
Pageof 11

Showing results (101-110 of 106) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 106 results.
Plos Pathogens|June 28, 2021
Tissue-specific transcriptional profiling of plasmacytoid dendritic cells reveals a hyperactivated state in chronic SIV infectionMichelle Y-H Lee, Amit A Upadhyay, Hasse Walum, et al.
Journal of Medical Virology|February 8, 2024
Genomic surveillance of omicron B.1.1.529 SARS-CoV-2 and its variants between December 2021 and March 2023 in Tamil Nadu, India-A state-wide prospective longitudinal studySivaprakasam T Selvavinayagam, Suvaiyarasan Suvaithenamudhan, Yean K Yong, et al.
Vaccine|June 23, 2011
Prime-boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: efficacy against repeated mucosal R5 clade C SHIV challengesSamir K Lakhashe, Vijayakumar Velu, Gaia Sciaranghella, et al.
PLOS Global Public Health|November 21, 2024
Attrition in serum anti-DENV antibodies correlates with high anti-SARS-CoV-2 IgG levels and low DENV positivity in mosquito vectors-Findings from a state-wide cluster-randomized community-based study in Tamil Nadu, IndiaSivaprakasam T Selvavinayagam, Sathish Sankar, Yean K Yong, et al.
Medrxiv : the Preprint Server for Health Sciences|June 17, 2024
Serosurveillance of dengue infection and correlation with mosquito pools for dengue virus positivity during the COVID-19 pandemic in Tamil Nadu, India - A state-wide cross-sectional cluster randomized community-based studySivaprakasam T Selvavinayagam, Sathish Sankar, Yean K Yong, et al.
Nature Communications|August 8, 2023
Intradermal but not intramuscular modified vaccinia Ankara immunizations protect against intravaginal tier2 simian-human immunodeficiency virus challenges in female macaquesVenkata S Bollimpelli, Pradeep B J Reddy, Sailaja Gangadhara, et al.
Pageof 11